Scott R Nodzo1, Nicholas B Frisch2. 1. Mike O'Callaghan Medical Center, 4700 N. Las Vegas Blvd, Las Vegas, NV, 89109, USA. Spodzo@gmail.com. 2. Ascension Crittenton Hospital, Rochester, MI, 48304, USA.
Abstract
PURPOSE OF REVIEW: Organism identification and antibiotic selection remain a critical component of periprosthetic joint infection (PJI) treatment. Prior to organism identification and/or the availability of antibiotic sensitivities, empiric antibiotics are routinely started. A basic understanding of a region or institutions antibiogram is paramount for selection of an empiric treatment regimen. Evolving antibiogram results and regional antibiotic resistance are important to follow as this may change antibiotic selection in some patient populations. RECENT FINDINGS: The Clinical Laboratory and Standards Institute (CLSI) has created guidelines and standards for the creation and maintenance of antibiograms that should be followed by institutions. The infecting organism during PJI may be different in acute vs chronic infections and empiric therapy may change depending on the timing. Antibiotic prophylaxis for major procedures in certain patient populations should be critically evaluated based on regional and national antibiogram results. The CLSI guides recommendations and antibiotic resistance testing techniques and should be consulted when creating an antibiogram. The local and regional antibiogram should be consulted prior to administration of empiric and prophylactic antibiotics.
PURPOSE OF REVIEW: Organism identification and antibiotic selection remain a critical component of periprosthetic joint infection (PJI) treatment. Prior to organism identification and/or the availability of antibiotic sensitivities, empiric antibiotics are routinely started. A basic understanding of a region or institutions antibiogram is paramount for selection of an empiric treatment regimen. Evolving antibiogram results and regional antibiotic resistance are important to follow as this may change antibiotic selection in some patient populations. RECENT FINDINGS: The Clinical Laboratory and Standards Institute (CLSI) has created guidelines and standards for the creation and maintenance of antibiograms that should be followed by institutions. The infecting organism during PJI may be different in acute vs chronic infections and empiric therapy may change depending on the timing. Antibiotic prophylaxis for major procedures in certain patient populations should be critically evaluated based on regional and national antibiogram results. The CLSI guides recommendations and antibiotic resistance testing techniques and should be consulted when creating an antibiogram. The local and regional antibiogram should be consulted prior to administration of empiric and prophylactic antibiotics.
Authors: Timothy L Tan; Miguel M Gomez; Michael M Kheir; Mitchell G Maltenfort; Antonia F Chen Journal: J Arthroplasty Date: 2016-11-23 Impact factor: 4.757
Authors: Atul F Kamath; Kevin L Ong; Edmund Lau; Vanessa Chan; Thomas P Vail; Harry E Rubash; Daniel J Berry; Kevin J Bozic Journal: J Arthroplasty Date: 2015-03-31 Impact factor: 4.757
Authors: Javad Parvizi; Ian M Pawasarat; Khalid A Azzam; Ashish Joshi; Erik N Hansen; Kevin J Bozic Journal: J Arthroplasty Date: 2010-05-31 Impact factor: 4.757
Authors: Bhaveen H Kapadia; Mark J McElroy; Kimona Issa; Aaron J Johnson; Kevin J Bozic; Michael A Mont Journal: J Arthroplasty Date: 2013-10-18 Impact factor: 4.757
Authors: Kevin J Bozic; Kevin Ong; Edmund Lau; Daniel J Berry; Thomas P Vail; Steven M Kurtz; Harry E Rubash Journal: Clin Orthop Relat Res Date: 2012-11-21 Impact factor: 4.176
Authors: Stephan Josef Maria Steixner; Christopher Spiegel; Dietmar Dammerer; Alexander Wurm; Michael Nogler; Débora Cristina Coraça-Huber Journal: Antibiotics (Basel) Date: 2021-06-29